IM Cannabis (IMCC) Fundamental Analysis: Revenue, Earnings & Valuation

8.07 / 10

Outperform

Fundamental assessment rates 8.1/10, indicating superior health. Interest coverage (15.6x) and inventory turnover (4.45) are strong, while YoY operating revenue declines (~‑4%) and high cost of sales (75%) raise concerns. Overall outlook remains very promising.

Analysis Checks(3/10)

Revenue-MV

Value1.55

Score2/3

Weight105.75%

1M Return4.88%

Total operating revenue (YoY growth rate %)

Value-4.05

Score1/3

Weight-6.53%

1M Return-0.38%

Inventory turnover ratio

Value4.45

Score2/3

Weight-19.01%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value96.08

Score0/3

Weight-70.45%

1M Return-4.96%

PB-ROE

Value-0.89

Score1/3

Weight134.73%

1M Return7.56%

Long-term debt to working capital ratio (%)

Value26.96

Score0/3

Weight-72.43%

1M Return-4.75%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-19.33%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value-4.05

Score1/3

Weight-5.13%

1M Return-0.30%

Cost of sales ratio (%)

Value75.40

Score1/3

Weight-98.26%

1M Return-7.95%

Asset-MV

Value-0.49

Score1/3

Weight150.64%

1M Return6.31%

Is IMCC undervalued or overvalued?

IMCC scores 8.07/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -21.47% net margin, -0.26 P/E ratio, -0.80 P/B ratio, and 37.83% earnings growth, these metrics solidify its Outperform investment rating.